- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
X-chem Inc.
Headquarters: Waltham, MA, United States of America
Website: http://www.x-chemrx.com
Year Founded: 2009
Status: Private
BioCentury | Jun 21, 2024
Management Tracks
ITM names Cavey CEO, plus PureTech, Brainstorm and more
Plus: New chairs for PureTech, Evexta and updates from PharmaEssentia, Brainstorm, Danaher and more
BioCentury | Sep 1, 2023
Management Tracks
Huguet to succeed Mayer at Ipsen
Plus: Junshi COO Hui departing, Kaufmann named CSO at Hansa
BioCentury | Aug 14, 2023
Management Tracks
Gardner named CEO of Flagship’s Ampersand
Plus: Brian Powl joins Kura as CCO, and updates from BioNTech, Allogene, CG and more
BioCentury | Jun 8, 2023
Management Tracks
New CFO, commercial officer at Pulmocide
Plus: Helmling named CBO at eTheRNA, and updates from EpimAb, Ring, Amarna, XNK and more
BioCentury | Feb 4, 2021
Deals
Feb. 3 Quick Takes: Hillhouse takes stakes in InnoCare, Luye; plus Merck KGaA, Inivata, Reverie, Neurocrine, Eisai and more
InnoCare Pharma Ltd. (HKEX:9969) raised HK$3 billion ($392 million) through the sale of 210.5 million shares at HK$14.45 to Hillhouse, which purchased 191.6 million shares for a 12.77% stake in the
BioCentury | Sep 13, 2019
Tools & Techniques
Getting higher-quality hits out of DNA-encoded libraries
DNA-encoded library developers are getting savvier about extracting the most promising hits
BioCentury | Mar 29, 2019
Targets & Mechanisms
AACR moves in a myeloid direction
A survey of the hot topics covered in this year’s AACR abstracts
BioCentury | Nov 9, 2018
Tools & Techniques
HitGen’s DNA for small molecules
How HitGen is amplifying DNA-encoded library-based drug design
Items per page:
1 - 10 of 31